EMP2 acts as a suppressor of melanoma and is negatively regulated by mTOR-mediated autophagy.

Abstract

Cutaneous melanoma is one of the most common malignant skin tumors and advanced melanoma is usually associated with a poor prognosis. In the current study, we demonstrated the tumor suppressing role of epithelial membrane protein-2 (EMP2) by inducing apoptosis in a A375 human melanoma cell line. Mechanistically, the low expression of EMP2 in melanoma is partially due to autophagic protein degradation mediated by the mTOR pathway. These results suggest there is regulation of autophagy as well as EMP2 levels might be an interesting novel targeted therapeutic strategy for melanoma. Although the further investigation is needed to deeply understand the regulatory mechanisms of EMP2 in melanoma progression and metastasis, our results clarify the functions and mechanisms of autophagy in melanoma, and shed new light on novel targeted therapeutics for melanoma.

• Authors: Manyi Wang, Sijia Li, Peng Zhang, Yujia Wang, Chunting Wang, Ding Bai, Xian Jiang
• Journal: Journal of Cancer (J Cancer) Vol. 10 Issue 16 Pg. 3582-3592 ( 2019) ISSN: 1837-9664 [Print] Australia
• PMID: 31333775 (Publication Type: Journal Article)